Fmoc-Lys(biotinyl-epsilon-aminocaproyl)-OH is an Fmoc-protected lysine derivative bearing a biotinylated epsilon-aminocaproyl substituent on the lysine side chain, where the backbone contains an amino group and a carboxyl group as part of an amino acid ester/acid form suitable for peptide assembly. The molecule features the Fmoc group on the alpha-amino functionality for orthogonal protection during stepwise coupling, while the side-chain epsilon-amine is acylated with an aminocaproyl linker terminated by a biotin moiety, providing a bioconjugation handle alongside the protected amide linkage. In peptide chemistry and chemical biology, it is used as a labeled or affinity-tagged lysine building block for preparing peptides or peptide-related intermediates that carry a biotin functional group for downstream detection, purification, or conjugation workflows.
CAT No: CP26443
CAS No:160158-05-4
Synonyms/Alias:C37H49N5O7S;160158-05-4;6952AH;ZINC150663853;Fmoc-Lys(biotinyl-epsilon-aminocaproyl)-OH
Fmoc-Lys(biotinyl-epsilon-aminocaproyl)-OH is an Fmoc-protected lysine derivative bearing a side-chain biotinylated ε-amide linker, with the stereogenic center of the lysine backbone preserved as the natural L-configuration. The molecule contains an Fmoc carbamate on the α-amino group, a free carboxylic acid for C-terminal compatibility, and a protected ε-amino functionality converted into an extended aminocaproyl amide that terminates in a biotin moiety. The biotinyl-epsilon-aminocaproyl side chain introduces a high-affinity biorecognition handle and additional amide and carbonyl functionalities that influence coupling behavior and downstream conjugation chemistry. The overall structure functions as a chiral, peptide-compatible building block in protected amino acid synthesis, with orthogonal deprotection and selective reactivity patterns enabled by the Fmoc group and the amide-linked biotin presentation.
1. Peptide Synthesis
Fmoc-Lys(biotinyl-epsilon-aminocaproyl)-OH is applied in solid-phase peptide synthesis and peptide fragment assembly where a biotin-functional lysine residue is required as a defined side-chain label. The Fmoc carbamate supports standard Nα-protection logic for iterative peptide coupling, while the ε-aminocaproyl biotin amide ensures the biorecognition element remains tethered through a flexible spacer that can reduce steric interference during synthesis and subsequent binding assays. The free α-carboxylic acid enables incorporation at the C-terminal position of a growing chain or as an internal residue depending on coupling order and protecting-group strategy. The resulting biotinylated peptide products can be used to generate affinity-tagged constructs for biochemical workflows and analytical readouts, while maintaining structural control over linker length and stereochemistry.
2. Bioconjugation Chemistry
Fmoc-Lys(biotinyl-epsilon-aminocaproyl)-OH serves as a chemically defined precursor for bioconjugation workflows that rely on biotin-avidin or biotin-streptavidin binding. The side-chain biotin moiety, presented via an aminocaproyl amide spacer, provides a conjugation handle that can be transferred into larger biomolecules through peptide coupling chemistry or post-synthetic modifications of peptide scaffolds. The Fmoc-protected α-amino group and the carboxylic acid functionality allow the compound to be integrated into peptide-based conjugates that maintain consistent biotin orientation relative to the peptide backbone. Downstream conjugate formation can be designed for surface immobilization, affinity purification, or multivalent labeling in research-grade biomolecule engineering and applied manufacturing of affinity reagents.
3. Chemical Biology Labeling
Fmoc-Lys(biotinyl-epsilon-aminocaproyl)-OH is suitable for chemical biology studies requiring site-specific labeling of peptides, proteins, or protein domains with a biotin tag embedded at a lysine position. The lysine side chain architecture, including the ε-amide-linked aminocaproyl spacer and the biotin ring system, supports controlled placement of the affinity handle while preserving the peptide's local charge distribution and hydrogen-bonding pattern. The Fmoc protection enables orthogonal handling during synthesis so that biotinylated labeling can be introduced without exposing reactive amines prematurely, supporting compatibility with peptide coupling and purification workflows. Biotinylated constructs produced from this building block can be employed in pull-down experiments, detection reagent preparation, and mechanistic studies where labeling position and linker length are critical for molecular recognition and assay reproducibility.
4. Peptidomimetics And SAR Studies
Fmoc-Lys(biotinyl-epsilon-aminocaproyl)-OH can be incorporated into peptidomimetic libraries and structure-activity relationship studies where a biotin tag is used to track binding, localization, or target engagement. The protected lysine backbone and the side-chain biotinylated aminocaproyl amide provide a stable, amide-rich scaffold that can be appended to analog series while keeping stereochemical identity consistent across analogs. The Fmoc group supports systematic construction of analog peptides, and the free carboxylic acid enables formation of defined termini that can influence conformation and coupling to other fragments. Biotin-tagged SAR panels can then be used to generate standardized affinity probes for comparative studies of molecular recognition, enabling downstream analytical correlation between structural modifications and biorecognition behavior.
5. Pharmaceutical Intermediate Preparation
Fmoc-Lys(biotinyl-epsilon-aminocaproyl)-OH is relevant to pharmaceutical intermediate preparation when biotinylated peptide building blocks are required for research material, reference standards, or process development tools used in analytical and manufacturing support. The compound's Fmoc-protected α-amino group and carboxylic acid functionality align with established protected amino acid handling strategies, including orthogonal deprotection and peptide coupling compatibility during controlled synthesis. The stable amide linkage connecting the lysine side chain spacer to the biotin moiety supports reliable transfer of the biotin functionality into larger peptide intermediates without requiring harsh conditions that could disrupt the affinity handle. The resulting biotinylated peptide intermediates can be used as defined reagents for method development, impurity tracking, and characterization workflows that depend on consistent labeling chemistry and reproducible structure.
6. Fine Chemical Synthesis
Fmoc-Lys(biotinyl-epsilon-aminocaproyl)-OH is utilized in fine chemical synthesis as a chiral, functionalized amino acid intermediate that integrates a biotin recognition element into a peptide-compatible framework. The molecule's combination of Fmoc-protected amine, α-carboxylic acid, and side-chain biotinylated aminocaproyl amide enables downstream derivatization into conjugate-ready scaffolds through peptide coupling chemistry and controlled deprotection sequences. The presence of multiple carbonyl-containing functional groups can support selective acylation or coupling logic when designing derivative series for affinity reagents, labeled standards, or specialty chemical intermediates. This amino acid derivative thus functions as a structured input for manufacturing of labeled biomolecular tools and for industrial-scale preparation of biotin-bearing peptide materials where stereochemical fidelity and functional group integrity are maintained through protected amino acid synthesis principles.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.